A new artificial intelligence model developed by USC researchers and published in Nature Methods can predict how different proteins may bind to DNA with accuracy across different types of protein, a technological advance that promises to reduce the time required to develop new drugs and other medical treatments.
Cancer drugs in US are ‘not affordable,’ says German study, which suggests setting drug prices by indication
US policymakers and payers should consider indication-based pricing in a bid to cut down on higher cancer drug costs in the US, according to research
August 31, 2023